Paul Hays

Chief Executive Officer at Vets Plus, Inc.

Paul Hays has a diverse and extensive work experience in the veterinary and animal health industry. Paul is currently serving as the Chief Executive Officer and Board Director for Vets Plus, Inc. Paul is also a Board Director for Bio Agri Mix LP and ControlPoint Inc. In addition, they are a Member of Vistage Worldwide, Inc.

Previously, Paul held the position of President & CEO at Med-Pharmex, Inc. where they successfully resolved FDA compliance issues and led the company to profitability and a successful sale. Paul also served as the Chief Commercial Officer at Vets Plus, Inc. and played a key role in its growth.

Prior to that, Paul worked at Virbac and held the role of President & CEO - Area Director North America. Paul was responsible for significant business transformations and the acquisition of new brands. Paul also held roles such as President Commercial Operations and led the turnaround of the St. business unit.

Paul'searlier career includes positions at Pfizer, where they served as Sr. Vice President, Global Diagnostics, and led the integration of Synbiotics. Paul was instrumental in the strategic planning and financial performance of the Global Diagnostic Business Unit.

Before Pfizer, Paul worked as the President & CEO at Synbiotics Corporation, where they successfully turned the company around and achieved record profits. Paul also held leadership roles at Boehringer Ingelheim Vetmedica Inc., including Executive Vice President, US Business Operations, Corporate Vice President Global Marketing & Area Operations, Vice President Swine Business Unit, Vice President Sales & Marketing, and Director of Marketing. In these roles, they led various strategic initiatives and drove sales growth and profitability.

Overall, Paul has a strong track record of leadership and success in the animal health industry, with expertise in business transformation, strategic planning, acquisitions, and compliance.

Paul Hays has a Bachelor of Science degree in Animal Science from the University of Missouri-Columbia. Paul also completed coursework towards an MBA at Syracuse University - Martin J. Whitman School of Management.

Links

Previous companies

Boehringer Ingelheim logo
Virbac logo
Pfizer logo

Timeline

  • Chief Executive Officer

    November, 2022 - present

  • Board Director

    December, 2021

  • Chief Commercial Officer

    January, 2019